MCL1 and hepatocellular carcinoma: To explore whether Mcl-1 decrease contributed to regulate YM-155 and ABT-263 co-treatment-induced apoptosis, we over-expressed Mcl-1 in HCC cells and found it could not neutralize the combination triggered cytotoxicity (data not shown).